Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer/Experiment 2

From BugSigDB


Needs review

Curated date: 2024/04/06

Curator: Ayibatari

Revision editor(s): Ayibatari

Subjects

Location of subjects
India
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Prostate gland Male prostate,Prostata,Prostate,Prostate gland,prostate gland
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Prostate carcinoma cancer of prostate,cancer of the prostate,carcinoma of prostate,carcinoma of prostate gland,carcinoma of the prostate,prostate cancer,prostate cancer, NOS,prostate carcinoma,prostate gland carcinoma,Prostate carcinoma
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Benign prostatic hyperplasia (BPH), Cohort-2 (Validation Cohort)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Prostate Cancer (PCa), Cohort-2 (Validation Cohort)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients who are diagnosed with Prostate Cancer (PCa).
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
16

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V9
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Metastats
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.00

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Richness Number of species
decreased

Signature 1

Needs review

Curated date: 2024/04/06

Curator: Ayibatari

Revision editor(s): Ayibatari

Source: FIGURE 2 D.

Description: Association of specific microbiota taxa (top 20 bacterial species) with BPH and PCa samples by LEfSe analyses. Green indicates taxa enriched in PCa samples.

Abundance in Group 1: increased abundance in Prostate Cancer (PCa), Cohort-2 (Validation Cohort)

NCBI Quality ControlLinks
Neisseria elongata
Leclercia adecarboxylata
Caulobacter segnis
Cupriavidus basilensis
Bradyrhizobium cytisi
Acinetobacter junii
Neisseria flavescens
Brevundimonas vancanneytii
Methylobacterium organophilum
Cupriavidus taiwanensis

Revision editor(s): Ayibatari

Signature 2

Needs review

Curated date: 2024/04/06

Curator: Ayibatari

Revision editor(s): Ayibatari

Source: FIGURE 2 D.

Description: Association of specific microbiota taxa (top 20 bacterial species) with BPH and PCa samples by LEfSe analyses. Orange indicates taxa enriched in BPH samples.

Abundance in Group 1: increased abundance in Prostate Cancer (PCa), Cohort-2 (Validation Cohort)

NCBI Quality ControlLinks
Kocuria palustris
Cellvibrio mixtus
Stutzerimonas stutzeri
Paracoccus sp. (in: a-proteobacteria)
Staphylococcus hominis
Corynebacterium tuberculostearicum
Brachybacterium paraconglomeratum
Staphylococcus arlettae
Staphylococcus cohnii
Anaerococcus octavius

Revision editor(s): Ayibatari